Prof. Satoshi KurodaJapan
Toyama University Hospital
| 2012 to present | Professor and Chairman, Department of Neurosurgery, University of Toyama, Toyama, Japan |
| 1986 - 1995 | Department of Neurosurgery, Hokkaido University, Sapporo, Japan |
| 1995 - 1997 | Wallenberg Neuroscience Center, Lund University, Lund, Sweden |
| 1998 - 2007 | Assistant Professor, Department of Neurosurgery, Hokkaido University, Sapporo, Japan |
| 2007 - 2012 | Associate Professor, Department of Neurosurgery, Hokkaido University, Sapporo, Japan |
cerebrovascular surgery, moyamoya disease, brain tumor, spinal disorders, cerebral blood flow and metabolism, non-human experiments
He is a skillful neurosurgeon and has operated on huge numbers of patients with cerebrovascular diseases for these 37 years. He is mainly interested in open surgery for cerebrovascular diseases, including carotid stenosis/occlusion, cerebral aneurysm, and moyamoya disease. He also has many experiences of surgery for brain tumor, spinal cord disorders, and trigeminal neuralgia/facial spasm. Total number of surgeries for these 10 years is over 2,000. His scientific interest is focused on basic and clinical research on cerebral hemodynamics and metabolism, cerebral ischemia, cell therapy for CNS disorders. He has conducted several multi-center clinical studies in Japan. He has published over 380 English-written articles that can be found in PubMed website.
Impact factor; 1,005 (1986-2024)
Citation; 19,115
h-index; 72
International collaboration on the diagnosis and treatment of moyamoya disease
1108 12:20-12:30
Cerebrovascular/304B
The author is a Chair of the Research Committee on Moyamoya Disease in Japan. Previously, the committee established the diagnosis criteria in 1978 and have repeated the revision according to new knowledge on the pathophysiology and imaging studies. However, I believe that we should widely discuss with international colleagues to develop a set of diagnostic criteria that is acceptable to everyone in the world. Treatment guidelines have been published in US, Europe, and Japan, which should be unified over the world. Currently, several countries are planning to set up databases and biobanks for moyamoya disease, but these should be designed from the beginning to allow for international collaboration.
Trans-nasal transplantation of stem cell
1108 16:00-16:10
AI & New Technology/304B
The author presents their recent results of non-human studies on trans-nasal transplantation of stem cells for the rodent models of ischemic stroke, traumatic brain injury, and Alzheimer's disease. The data include the impact of trans-nasal transplantation of stem cells on neurological deficits and histological findings in each animal model. Trans-nasal transplantation of stem cells would be a promising strategy for both acute and chronic central nervous system disorders.